AVTE logo

Aerovate Therapeutics (AVTE) Depreciation And Amortization

AVTE Annual D&A

$96.00 K
+$28.00 K+41.18%

31 December 2023

AVTE Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AVTE Quarterly D&A

$218.00 K
+$190.00 K+678.57%

30 September 2024

AVTE Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AVTE TTM D&A

$302.00 K
+$193.00 K+177.06%

30 September 2024

AVTE TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AVTE Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+41.2%+678.6%+214.6%
3 y3 years+9500.0%+678.6%+214.6%
5 y5 years+100.0%+678.6%+214.6%

AVTE Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+540.0%at high+2625.0%at high+1913.3%
5 y5-yearat highat highat high
alltimeall timeat highat highat high

Aerovate Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$218.00 K(+678.6%)
$302.00 K(+177.1%)
June 2024
-
$28.00 K(0.0%)
$109.00 K(+5.8%)
Mar 2024
-
$28.00 K(0.0%)
$103.00 K(+7.3%)
Dec 2023
$96.00 K(+41.2%)
$28.00 K(+12.0%)
$96.00 K(+9.1%)
Sept 2023
-
$25.00 K(+13.6%)
$88.00 K(+6.0%)
June 2023
-
$22.00 K(+4.8%)
$83.00 K(+6.4%)
Mar 2023
-
$21.00 K(+5.0%)
$78.00 K(+14.7%)
Dec 2022
$68.00 K
$20.00 K(0.0%)
$68.00 K(+21.4%)
Sept 2022
-
$20.00 K(+17.6%)
$56.00 K(+43.6%)
June 2022
-
$17.00 K(+54.5%)
$39.00 K(+62.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
$11.00 K(+37.5%)
$24.00 K(+60.0%)
Dec 2021
$15.00 K(+1400.0%)
$8000.00(+166.7%)
$15.00 K(+87.5%)
Sept 2021
-
$3000.00(+50.0%)
$8000.00(+60.0%)
June 2021
-
$2000.00(0.0%)
$5000.00(+66.7%)
Mar 2021
-
$2000.00(+100.0%)
$3000.00(+200.0%)
Dec 2020
$1000.00(>+9900.0%)
$1000.00(>+9900.0%)
$1000.00(>+9900.0%)
Sept 2020
-
$0.00(0.0%)
$0.00(0.0%)
June 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$0.00
-
-

FAQ

  • What is Aerovate Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Aerovate Therapeutics?
  • What is Aerovate Therapeutics annual D&A year-on-year change?
  • What is Aerovate Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Aerovate Therapeutics?
  • What is Aerovate Therapeutics quarterly D&A year-on-year change?
  • What is Aerovate Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Aerovate Therapeutics?
  • What is Aerovate Therapeutics TTM D&A year-on-year change?

What is Aerovate Therapeutics annual depreciation & amortization?

The current annual D&A of AVTE is $96.00 K

What is the all time high annual D&A for Aerovate Therapeutics?

Aerovate Therapeutics all-time high annual depreciation & amortization is $96.00 K

What is Aerovate Therapeutics annual D&A year-on-year change?

Over the past year, AVTE annual depreciation & amortization has changed by +$28.00 K (+41.18%)

What is Aerovate Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of AVTE is $218.00 K

What is the all time high quarterly D&A for Aerovate Therapeutics?

Aerovate Therapeutics all-time high quarterly depreciation & amortization is $218.00 K

What is Aerovate Therapeutics quarterly D&A year-on-year change?

Over the past year, AVTE quarterly depreciation & amortization has changed by +$190.00 K (+678.57%)

What is Aerovate Therapeutics TTM depreciation & amortization?

The current TTM D&A of AVTE is $302.00 K

What is the all time high TTM D&A for Aerovate Therapeutics?

Aerovate Therapeutics all-time high TTM depreciation & amortization is $302.00 K

What is Aerovate Therapeutics TTM D&A year-on-year change?

Over the past year, AVTE TTM depreciation & amortization has changed by +$206.00 K (+214.58%)